SecBot SecBot

SCNI

Scinai Immunotherapeutics Ltd.
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. L3· CIK 0001611747 Biotech & Drug Discovery
$0.5420 −0.02 (−4.07%)
Oct 26 4:00 PM ET · prev $0.5650
Market cap
$2.3M
Nano cap
1 year
−96.3%
from $14.62 · Oct 27
30 days
−63.1%
from $1.47
52-week range
$0.5420–15.00
at the low
Avg volume 20D
3.43M
Oct 13 spike 64.10M
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
15
analyzed by SecBot
SecBot read BEARISH 9 reports · 90 days
Balance 6 bearish · 1 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 7/9
Strongest BEARISH Scinai Immunotherapeutics closed a $4.0 million private placement and warrant inducement transaction…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 2 added (0 new), 0 trimmed or exited.

  • TrendDOWNTREND

    68% below its 50-day average. New closing low $0.5420 on Oct 26.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 14.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
RHUMBLINE ADVISERSDOUBLED13,513$3.4K
UBS Group AGDOUBLED3,955$1.0K
UBS Group AGTRIM919$524.00
RHUMBLINE ADVISERSTRIM1,878$1.3K
UBS Group AGDOUBLED1,748$1.2K
MORGAN STANLEYNEAR_EXIT58$41.00
CITADEL ADVISORS LLCDOUBLED28,630$36.2K
UBS Group AGNEAR_EXIT8$10.00

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 16, 2026
Offering
Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement
JERUSALEM, Oct. 16, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company…
Sep 21, 2026
Press release
Scinai Regains Compliance with Nasdaq Minimum Bid Price Requirement
Nasdaq confirms compliance with Listing Rule 5550(a)(2) after 19 consecutive business days with a closing bid price at or above $1.00; minimum bid…
Sep 18, 2026
Listing
Listing Status: SCNI — Normal (was Deficient)
Scinai Immunotherapeutics Ltd. - American Depositary Shares | Nasdaq Financial Status Indicator D → N
Aug 24, 2026
Earnings
Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum
Investor webinar scheduled for August 26, 2026 at 11:00 a.m. EDT JERUSALEM, Aug. 24, 2026 /PRNewswire/ – Scinai Immunotherapeutics Ltd. (NASDAQ…
Aug 21, 2026
Trading halt
Halt Resumed: SCNI — trading resumed after T3 (News and Resumption Times)
Halted 2026-08-20T23:50:00.000Z | Resumed 2026-08-21T13:00:00.000Z

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jun 16, 2026
Reichman Amir
Chief Executive Officer
AWARD400,000,000 sh
Jun 16, 2026
GERMAIN MARK
Director
AWARD120,000,000 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Reddit mentions per day, 14 days
Recent posts
r/pennystocks Neutral 13d ago
14 OCT 2026 , WHAT ARE THE BIGGEST LOSERS AND WHY ?
2 upvotes · 1 comments
r/pennystocks Neutral 14d ago
13 OCT 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY ?
1 upvotes · 1 comments
All social signals and their track records

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Trading halts
Aug 20, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 20, 2026 SEC
Scinai CEO issued a shareholder letter detailing a $5.1M committed CDMO agreement, a $5.3M combined net financing, and…
6-K — Impact 4/10
Oct 16, 2026 SEC
Scinai Immunotherapeutics closed a $4.0 million private placement and warrant inducement transaction, issuing…
6-K — Impact 6/10
Oct 16, 2026 Press
Scinai closed a $4.0M private placement and warrant inducement, issuing ~2.46M ADSs and warrants for up to ~5.0M…
Impact 5/10
Oct 16, 2026 Offering
Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement
JERUSALEM, Oct. 16, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) ("Scinai" or
Oct 15, 2026 SEC
Scinai Immunotherapeutics entered into a securities purchase agreement on October 13, 2026, to sell ADSs and…
6-K — Impact 6/10
Jun 30, 2026 Inst.
RHUMBLINE ADVISERS — DOUBLED
13,513 shares ($3.4K)
Jun 30, 2026 Inst.
UBS Group AG — DOUBLED
3,955 shares ($1.0K)
Jun 16, 2026 Insider
Reichman Amir was granted 400,000,000 shares
Chief Executive Officer

SecBot reports

15 filings · 1 press release · 1 bullish · 10 bearish · 4 neutral
All SCNI filing & press-release reports (16)